Sarah Bos

110 CHAPTER 6 31 Lisman T, Kleiss S, Patel VCVC, Fisher C, Adelmeijer J, Bos S, Singanayagam A, Stoy SHSH, Shawcross DLDL, Bernal W. In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosis. Liver Int 2018; 38: 1988–96. 32 Yoshiya S, Shirabe K, Nakagawara H, Soejima Y, Yoshizumi T, Ikegami T, Yamashita YI, Harimoto N, Nishie A, Yamanaka T, Maehara Y. Portal vein thrombosis after hepatectomy. World J Surg 2014; 38: 1491–7. 33 Machlus KR, Cardenas JC, Church FC, Wolberg AS. Causal relationship between hyperfibrin- ogenemia, thrombosis, and resistance to thrombolysis in mice. Blood 2011; 117: 4953–63. 34 van Hylckama Vlieg A, Rosendaal FR. High levels of fibrinogen are associated with the risk of deep venous thrombosis mainly in the elderly. J Thromb Haemost 2003; 1: 2677–8. 35 Kleiss SF, Adelmeijer J, Meijers JCM, Porte RJ, Lisman T. A sustained decrease in plasma fibrinolytic potential following partial liver resection or pancreas resection. Thromb Res 2016; 140: 36-40. 36 Groeneveld DJ, Alkozai EM, Adelmeijer J, Porte RJ, Lisman T. Balance between von Wille- brand factor and ADAMTS13 following major partial hepatectomy. Br J Surg 2016; 103: 735-743. 37 Pereboom ITA, Adelmeijer J, Van Leeuwen Y, Hendriks HGD, Porte RJ, Lisman T. Development of a severe von willebrand factor/adamts13 dysbalance during orthotopic liver transplantation. Am J Transplant 2009; 9: 1189-96. 38 Morrow GB, Beavis J, Harper S, Baker P, Desbourough MJR, Curry N, Stanworth SJ, Laffan MA. Coagulation status of critically ill patients with and without liver disease assessed using a novel thrombin generation analyser. J Thromb Haemost 2020, in press. 39 Wan J, Roberts LN, Hendrix W, Konings J, Ow TW, Rabinowich L, Barbouti O, de Laat B, Arya R, Patel VC, Roest M, Lisman T, Bernal W. Whole blood thrombin generation profiles of patients with cirrhosis explored with a near patient assay. J Thromb Haemost 2020; 18: 834-843. 40 Chavez-Tapia NC, Alfaro-Lara R, Tellez-Avila F, Barrientos-Gutiérrez T, González-Chon O, Mendez-Sanchez N, Uribe M. Prophylactic activated recombinant factor VII in liver resection and liver transplantation: Systematic review and meta-analysis. PLoS One 2011; 6: 1–8. 41 Weeder PD, Porte RJ, Lisman T. Hemostasis in liver disease: Implications of new concepts for perioperative management. Transfusion Medicine Reviews. 2014; 28:107–13. 42 Tripodi A, Chantarangkul V, Primignani M, Clerici M, Dell’Era A, Aghemo A, Mannucci PM. Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: Considerations on the efficacy of treatment with fresh-frozen plasma. Intern Emerg Med 2012; 7: 139–44. 43 Bezinover D, Dirkmann D, Findlay J, Guta C, Hartmann M, Nicolau-Raducu R, Mukhtar AM, Moguilevitch M, Pivalizza E, Rosenfeld D, Saner F, Wray C, Wagener G, West J. Perioperative coagulation management in liver transplant recipients. Transplantation 2018; 102: 578–92. 44 Abuelkasem E, Hasan S, Mazzeffi MA, Planinsic RM, Sakai T, Tanaka KA. Reduced Requirement for Prothrombin Complex Concentrate for the Restoration of Thrombin Generation in Plasma From Liver Transplant Recipients. Anesth Analg 2017; 125: 609–15. 45 Krzanicki D, Sugavanam A, Mallett S. Intraoperative hypercoagulability during liver transplantation as demonstrated by thromboelastography. Liver Transplant 2013; 19: 852–61.